ATCC Vector-borne Research Materials – New!
Billions of people worldwide are at risk from microorganisms transmitted by mosquitoes, ticks, fleas, and other vectors. Due to the complexity of vector-borne pathogen transmission, and the unpredictable nature of insect vectors, vector-borne illnesses are among the most difficult infectious diseases to predict, prevent, and control.
To help support the development of molecular-based assays for pathogen detection or quantification, ATCC is pleased to announce the release of genomic DNA isolated from Babesia microti, and synthetically-derived RNA representing Dengue virus types I-IV.
|30221D||Genomic Babesia microti DNA||Frozen||≥ 5 x 103 copies/µL|
|VR-3228SD||Synthetic Dengue virus type 1 RNA||Frozen||1x 105 – 1 x 106 copies/ µL|
|VR-3229SD||Synthetic Dengue virus type 2 RNA||Frozen||1x 105 – 1 x 106 copies/ µL|
|VR-3230SD||Synthetic Dengue virus type 3 RNA||Frozen||1x 105 – 1 x 106 copies/ µL|
|VR-3231SD||Synthetic Dengue virus type 4 RNA||Frozen||1x 105 – 1 x 106 copies/ µL|
These ATCC® Genuine Nucleics can be used for assay development, verification, validation, monitoring of day-to-day test variation, and lot-to-lot performance of molecular-based assays. Moreover, their quantitative format allows for the generation of a standard curve for quantitative PCR (qPCR).
For more information on vector-borne illnesses, or to search for strains and nucleic acids to support your research, please visit us online at www.atcc.org/vectorborne.
Date Published: 25th August 2014
Source article link: ATCC
Cherwell Offers Process Validation Advice
Real-Time RT-PCR Kits for Ebola